Brief: Immunovia Provides Complementary Details On Immray Pancan-D Verification Study

Immunovia AB (publ)

02/11/2020 18:52

Nov 2 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * PROVIDES COMPLEMENTARY DETAILS ON THE IMMRAY ™  PANCAN-D
VERIFICATION STUDY
    * AS ANNOUNCED LAST WEEK, RESULTS SHOWED ACCURACY OF 94% IN
DIFFERENTIATING EARLY STAGE I/II PDAC PATIENTS FROM HEALTHY
CONTROLS
    * NOW REPORT  SPECIFICITY OF 99%,SENSITIVITY OF 78% FOR THIS
COMPARISON, YIELDING HIGH NPV OF 0.993, WHICH MINIMIZE NUMBER OF
FALSE POSITIVE

Source text for Eikon:  ID:nWkr93tnFD 
Further company coverage:  IMMNOV.ST 

 ((Reuters.Briefs@thomsonreuters.com;))